Regeneron Pharmaceuticals (REGN)

Add to Watchlists Create an Alert
250.31 -4.56  -1.79%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Regeneron Pharmaceuticals Net Income Quarterly:

98.87M for March 31, 2013
View Full Chart

Regeneron Pharmaceuticals Net Income Quarterly Chart

    Regeneron Pharmaceuticals Historical Net Income Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 98.87M
    Dec. 31, 2012 470.41M
    Sept. 30, 2012 191.47M
    June 30, 2012 76.74M
    March 31, 2012 11.65M
    Dec. 31, 2011 -53.44M
    Sept. 30, 2011 -62.36M
    June 30, 2011 -62.50M
    March 31, 2011 -43.45M
    Dec. 31, 2010 -14.60M
    Sept. 30, 2010 -33.88M
    June 30, 2010 -25.47M
    March 31, 2010 -30.52M
    Dec. 31, 2009 -36.49M
    Sept. 30, 2009 -1.015M
    June 30, 2009 -14.94M
    March 31, 2009 -15.39M
    Dec. 31, 2008 -27.94M
    Sept. 30, 2008 -21.12M
    June 30, 2008 -18.69M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Net Income

    Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.

    Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
    Learn More

    Get data for

    REGN Net Income Quarterly Benchmarks

    Companies
    Sanofi 1.287B
    Celgene Corporation 384.90M
    Exelixis -44.73M

    REGN Net Income Quarterly Rankings

    Overall 91st percentile
    648 of 7600
    Sector 91st percentile
    53 of 653 in Healthcare
    Industry 97th percentile
    7 of 238 in Biotechnology

    REGN Net Income Quarterly Range, Past 5 Years

    Minimum -62.51M Jun 2011
    Maximum 470.41M Dec 2012
    Average 19.37M